Goshen Health Taps MedCerts to Solve Healthcare Talent Shortage

LIVONIA, Mich.–(BUSINESS WIRE)–#healthcare—MedCerts, a leader in online healthcare and IT certification training, has teamed with Goshen Health to address vacancies and shortages of their frontline healthcare workers. Through this train-and-hire partnership, MedCerts — a Stride, Inc. company (NYSE: LRN) — will support the recruitment and clinical training for Medical Assistants and Medical Billing positions at … [Read more…]

Global Gene Synthesis Market Report to 2027 – Rising Efforts Toward Clinical Researches to Study Biological Systems is Driving Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Gene Synthesis Market By Method, By Service Type, By Application, By End User, By Regional Outlook, Industry Analysis Report and Forecast, 2021-2027” report has been added to ResearchAndMarkets.com’s offering. The Global Gene Synthesis Market size is expected to reach $5.2 billion by 2027, rising at a market growth of 17.9% CAGR during … [Read more…]

Taiwan Excellence’s “Explore Every Terrain” Pavilion Showcases Trailblazing Products at Outdoor Retailer Summer Show

Pavilion features 11 innovative companies displaying products for cycling, camping, hiking, swimming and much more DENVER, Colorado,–(BUSINESS WIRE)–#ASUS—Outdoor Retailer Summer Show – With the theme “Explore Every Terrain,” the Taiwan External Trade Development Council (TAITRA), Taiwan’s foremost trade promotion organization, is set to exhibit a multitude of fun and innovative outdoor products at the 2022 … [Read more…]

Microban 24 Multi-Purpose Cleaner is Now the First Consumer Product Registered to Keep Killing Bacteria and Viruses that Cause the Flu and COVID-19 for up to 24 hours

CINCINNATI–(BUSINESS WIRE)–The U. S. Environmental Protection Agency (EPA) has registered Microban 24 Multi-Purpose Cleaner (EPA Reg No. 4091-21-3573) to keep killing 99.9% of bacteria & viruses that cause the flu and COVID-19, for up to 24 hours, even when the surface is touched or contacted multiple times1. While it had previously been registered by the … [Read more…]

Rallybio to Present at Upcoming Investor Conferences in June

NEW HAVEN, Conn.–(BUSINESS WIRE)–Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare diseases, today announced its participation in the following upcoming investor conferences: Jefferies Healthcare Conference in New York, NY on Wednesday, June 8, 2022 at 10:30 a.m. ET. JMP … [Read more…]

Wugen to Participate in Upcoming June Investor Conferences

ST. LOUIS & SAN DIEGO–(BUSINESS WIRE)–Wugen, Inc., a clinical-stage biotechnology company developing a pipeline of off-the-shelf cell therapies to treat a broad range of hematological and solid tumor malignancies, today announced that management will participate in two upcoming investor conferences in June: Jefferies Healthcare Conference Format: Presentation Presentation Date/Time: Wednesday, June 8, 2022 at 4:30 … [Read more…]

AtriCure Announces the Appointment of Deborah Yount as Chief Human Resources Officer

MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, announced the appointment of Deborah Yount as Chief Human Resources Officer, effective today. Ms. Yount will have responsibility for global Human Resources activities. “We are excited to have … [Read more…]

Asher Bio Announces Clinical Trial Collaboration with Merck to Evaluate AB248 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Locally Advanced or Metastatic Solid Tumors

Trial evaluating AB248, a CD8+ T cell cis-targeted IL-2 immunotherapy, in combination with KEYTRUDA, Merck’s anti-PD-1 therapy, aims to address unmet need for patients who are non-responsive to previous anti-PD-1 therapy or enhance current standard of care in an early line of therapy SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Asher Biotherapeutics, a biotechnology company developing precisely-targeted immunotherapies … [Read more…]

Arrakis Therapeutics to Present at Jefferies Healthcare Conference

WALTHAM, Mass.–(BUSINESS WIRE)–Arrakis Therapeutics, a biopharmaceutical company pioneering the discovery of a new class of small molecule medicines that directly target RNA, today announced that Michael Gilman, Ph.D., Chief Executive Officer, will present a corporate overview at the Jefferies Healthcare Conference on Thursday, June 9, 2022 at 3:30 p.m. ET in New York. About Arrakis … [Read more…]

Miroculus Partners with Element Biosciences to Validate the Miro Canvas Digital Microfluidics Platform for the AVITI™ System

SAN FRANCISCO–(BUSINESS WIRE)–Miroculus, Inc., developer of revolutionary tools for personal lab automation, today announced its partnership with Element Biosciences, Inc., developer of the AVITI System, a new and disruptive DNA sequencing platform launched on March 14th, to demonstrate seamless library preparation compatibility of the Miro Canvas digital microfluidics platform with the AVITI System. As technologies … [Read more…]